30 results on '"Hiramatsu, Katsutoshi"'
Search Results
2. Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review.
3. 72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension
4. Insights on diagnosis and therapeutic decision-making patterns for multiple sclerosis treatment: cross-sectional opinion survey results from Japanese neurologists
5. Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study)
6. Study of Sustained Blood Pressure-Lowering Effect of Azelnidipine Guided by Self-Measured Morning and Evening Home Blood Pressure: Subgroup Analysis of the At-HOME Study
7. Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
8. Artist® Tablets (Carvedilol) for Hypertensive Patients in Japan: Results of a Long-Term Special Survey
9. Artist® Tablets (Carvedilol) for Hypertensive Patients in Japan: Results of a Drug Use Survey
10. Olmesartan medoxomil and azelnidipine therapy in patients with hypertension and chronic kidney disease in Japan
11. The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study
12. Supplemental material for Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study
13. Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study
14. Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study
15. Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study)
16. Enhanced Blood Pressure–Lowering Effect of Olmesartan in Hypertensive Patients With Chronic Kidney Disease–Associated Sympathetic Hyperactivity: HONEST Study
17. Clinical Status and Outcome of Japanese Heart Failure Patients With Reduced or Preserved Ejection Fraction Treated With Carvedilol
18. Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study
19. 513 HONEST (HOME BLOOD PRESSURE MEASUREMENT WITH OLMESARTAN NAIVE PATIENTS TO ESTABLISH STANDARD TARGET BLOOD PRESSURE) STUDY. RATIONALE, DESIGN, AND BASELINE CHARACTERISTICS
20. Olmesartan medoxomil and azelnidipine therapy in patients with hypertension and chronic kidney disease in Japan
21. A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine Treatment for Hypertension in the Early Morning (At-HOME) Study
22. Estimating Antihypertensive Effects of Combination Therapy in an Observational Study Using Marginal Structural Models
23. Blood Pressure-Lowering Effects of Angiotensin Receptor Antagonist Monotherapy and in Combination with Other Anti-Hypertensive Drugs in Primary Care Settings in Japan
24. Influence of Guidelines on Physicians' Assessment of Blood Pressure Lowering Effects and Achievement Rate of Blood Pressure Target During Transitional Period of Guidelines
25. Early Antihypertensive Efficacy of Olmesartan Medoxomil
26. The Use of Olmesartan Medoxomil as Monotherapy or in Combination With Other Antihypertensive Agents in Elderly Hypertensive Patients in Japan
27. Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study risk factor sub-analysis.
28. Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study.
29. Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study.
30. Artist® Tablets (Carvedilol) for Hypertensive Patients in Japan
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.